Detalhe da pesquisa
1.
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.
J Gastroenterol Hepatol
; 39(4): 658-666, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38251791
2.
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China.
BMC Cancer
; 23(1): 930, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784037
3.
RASSF1A inhibits epithelial-mesenchymal transition of gastric cancer cells by downregulating P-JNK.
Cell Biol Int
; 47(3): 573-583, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404583
4.
Application of pyroptosis score in the treatment and prognosis evaluation of gastric cancer. / ç»èç¦äº¡è¯åå¨èçæ²»çåé¢åè¯ä¼°ä¸çåºç¨.
Zhong Nan Da Xue Xue Bao Yi Xue Ban
; 48(12): 1882-1889, 2023 Dec 28.
Artigo
em Inglês, Zh
| MEDLINE | ID: mdl-38448382
5.
Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
J Transl Med
; 20(1): 296, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35773729
6.
Efficacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: a multicenter, prospective, single-arm, phase 2 trial.
BMC Cancer
; 22(1): 722, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35778685
7.
Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial.
J Gastroenterol Hepatol
; 37(11): 2060-2066, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068945
8.
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Age Ageing
; 51(1)2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673897
9.
Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study.
Ann Hematol
; 100(3): 709-714, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483774
10.
Linc00483 as ceRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer.
J Cell Mol Med
; 22(8): 3875-3886, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761936
11.
Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway.
Mol Cell Biochem
; 433(1-2): 141-148, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405849
12.
The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells.
Mol Cell Biochem
; 424(1-2): 185-193, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785703
13.
Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal.
Mol Cell Biochem
; 434(1-2): 25-32, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397012
14.
Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.
Clin Exp Pharmacol Physiol
; 44(10): 1032-1041, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664617
15.
Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells.
Tumour Biol
; 35(8): 8023-31, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839008
16.
High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.
Tumour Biol
; 35(9): 8625-32, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24867097
17.
MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis.
J Exp Clin Cancer Res
; 43(1): 68, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439082
18.
Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia.
Blood
; 118(10): 2793-800, 2011 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768294
19.
Patient Journey Toward a Diagnosis of Light Chain Amyloidosis in a National Sample: Cross-Sectional Web-Based Study.
JMIR Form Res
; 7: e44420, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917132
20.
Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China.
Front Oncol
; 13: 1028571, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37152063